IL1A and Creutzfeldt Jacob disease: In a mouse model of CJD, pharmacological inhibition of astrocytic IL-1R signaling could restore normal synaptic responses and reduce seizure susceptibility, suggesting that targeting IL-1 signaling may offer a novel symptomatic treatment for CJD [111].